AdaptHealth Corp. (NASDAQ:AHCO) shares plunged nearly 13% in pre-market trading after the home medical equipment provider reported second-quarter 2026 results that fell short of Wall Street expectations and sharply reduced its financial outlook for the year.
The weaker-than-expected performance was accompanied by lower guidance for revenue, adjusted EBITDA and free cash flow
Earnings and Revenue Miss Forecasts AdaptHealth reported a quarterly loss of $0.99 per share, compared with analyst expectations for earnings of $0.15 per share. Revenue totalled $740.3 million, missing the consensus estimate of $848.89 million. Despite the shortfall, sales were 12.7% higher than the $657.1 million reported in the same quarter last year.
The company also recorded organic revenue growth of 15.9% across all of its business segments. CEO Points to Strong Demand but Margin Pressure Chief Executive Officer Suzanne Foster said demand remained robust despite operational challenges. “The company delivered 15.9% organic growth, with record volume gains across the business,” Foster said, adding that “the complexity of that transition has impacted our margins.” Company Cuts Full-Year Outlook AdaptHealth significantly lowered its fiscal 2026 guidance. The company now expects revenue of between $2.85 billion and $2.89 billion, well below the analyst consensus estimate of approximately $3.486 billion.